MPE webinar on big data in haematology, the Harmony example
Myeloma Patients Europe (MPE) will hold a webinar on big data in hematology on Thursday 2 April 2020 from 18:00 – 19:00 CET.
EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE
Myeloma Patients Europe (MPE) will hold a webinar on big data in hematology on Thursday 2 April 2020 from 18:00 – 19:00 CET.
Myeloma Patients Europe (MPE) has put together an advice sheet for our members and myeloma patients on coronavirus (Covid-19). This advice has been reviewed by our scientific advisors and will be continually updated to reflect the latest information.
Myeloma Patients Europe (MPE) will hold a webinar on reimbursement and Health Technology Assessment (HTA) on Wednesday 18 March 2020 from 18:00 – 19:00 CET.
Myeloma Patients Europe (MPE) held a webinar yesterday on myeloma and AL amyloidosis treatment update given by Dr Inger Nijhof, Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
As part of the educational programme planned to replace the Masterclass included in the MPE Annual General Meeting (AGM) 2020, which was cancelled due to the outbreak of the coronavirus infection, MPE is organising a Webinars series.
Myeloma Patients Europe (MPE) will hold a webinar on myeloma and AL amyloidosis treatment updates on Wednesday 11 March 2020 from 18:30 – 19:30 CET.
Myeloma Patients Europe (MPE), in collaboration with the pharmaceutical company Amgen, launched a survey in 2019 for European myeloma patients to understand their treatment information needs.
Myeloma Patients Europe (MPE) held a webinar yesterday on ASH 2019 myeloma and AL amyloidosis highlights with the aim of reviewing the most recent myeloma findings presented at the annual meeting of the American Society of Hematology (ASH) that took place in Orlando, Florida, USA, in December 2019.
Myeloma Patients Europe will hold a webinar to review the most recent myeloma findings presented at the annual meeting of the American Society of Hematology (ASH) that took place in Orlando, Florida, USA, in December 2019.